Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Bel-Art Introduces New Magic Touch 2™ Icewares

Published: Thursday, July 26, 2012
Last Updated: Wednesday, July 25, 2012
Bookmark and Share
Superior insulation properties and features abound with the new Scienceware® Magic Touch 2™ ice buckets and ice pans.

For over twenty years Magic Touch™ Ice Buckets and Ice Pans have set the standard for durability and performance in the laboratory.

But a good thing can get better and Bel-Art Products is ready to prove it with the introduction of Magic Touch 2™ icewares.

“In addition to superior insulation properties, chemical resistance, and all the other features that have made Magic Touch™ icewares popular, new features of Magic Touch 2™ include a convenient pour spout to easily drain unwanted ice melt, drip-proof rims that keep the bench dry, and snug-fitting, keyed lids and bases for easy stacking,” according to Robert N. Petersen, Product Manager for Bel-Art Products.

Petersen continued, “Their lightly textured, non-slip finish and raised edge provides secure transport and a stylish look.”

Magic Touch 2™ Icewares are compatible not only with wet ice, but also with ultra-low temperature materials including dry ice, salt slurries, dry ice solvent slurries, or liquid nitrogen.

Able to withstand a wide temperature range of -196°C (-320°F) to 100°C (212°F), these high-quality, expanded urethane icewares are lightweight, durable, non-sweating and impervious to moisture and odors.

Scienceware® Magic Touch 2™ Ice Buckets are available in 2.5L and 4.0L sizes with lids. Ice Pans are available in 1.0L, 4.0L and 9.0L sizes with lid, and the 9.0L size without lid.

All are available in four vibrant new colors; ebony, true blue, cherry red and emerald green. Suggested list price ranges from $65.00 to $140.00.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Discovering the First Farmers
Genetic analyses reveal a collection of highly distinct groups in the Near East and Europe at the dawn of agriculture.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!